NCT07195162 Validating and Evaluating the Pain Medicine Digital Workflow Algorithm (PGS 1.0)
| NCT ID | NCT07195162 |
| Status | Recruiting |
| Phase | — |
| Sponsor | PG Medical Systems Ltd. |
| Condition | Chronic Pain |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2025-09-17 |
| Primary Completion | 2026-03-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2025-09-17 with a primary completion date of 2026-03-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a prospective, non-randomized, double blind, single center, single arm, validation study, to evaluate the performance of PGS 1.0 algorithm in analyzing pain specific symptoms and medical history data of pain patients referred to a pain expert consultation.
Eligibility Criteria
Inclusion Criteria: * Patient is willing and capable of providing Informed Consent. * Pain persisting for at least 1 month. Exclusion Criteria: None
Contact & Investigator
Simon Vulfsons, MD
PRINCIPAL INVESTIGATOR
Rambam Health Care Campus
Frequently Asked Questions
Who can join the NCT07195162 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Chronic Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07195162 currently recruiting?
Yes, NCT07195162 is actively recruiting participants. Contact the research team at shany@pgmeds.com for enrollment information.
Where is the NCT07195162 trial being conducted?
This trial is being conducted at Haifa, Israel.
Who is sponsoring the NCT07195162 clinical trial?
NCT07195162 is sponsored by PG Medical Systems Ltd.. The principal investigator is Simon Vulfsons, MD at Rambam Health Care Campus. The trial plans to enroll 200 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.